Huizinga Robert Bindert insider trades
Huizinga Robert Bindert has filed 5 Form 4s with the SEC that we hold, all for Aurinia Pharmaceuticals Inc. (AUPH), as EVP of Research. Across all of them we count 0 purchases worth $0 and 8 sales worth $5.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 130,000 shares of Aurinia Pharmaceuticals Inc. worth $3.9M, dated 2021-10-25. The first filing on our record is dated 2021-09-08 and the latest 2022-03-04.
Aurinia Pharmaceuticals Inc. (AUPH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-07 | S, sale reported on Form 4 | 5,000 | $91.5K | 2021-09-08 |
| 2021-09-10 | S, sale reported on Form 4 | 5,000 | $98.8K | 2021-09-14 |
| 2021-09-10 | S, sale reported on Form 4 | 5,000 | $99.1K | 2021-09-14 |
| 2021-09-14 | S, sale reported on Form 4 | 22,500 | $489.4K | 2021-09-14 |
| 2021-09-21 | S, sale reported on Form 4 | 27,136 | $652.6K | 2021-09-22 |
| 2021-09-21 | S, sale reported on Form 4 | 5,364 | $126.9K | 2021-09-22 |
| 2021-10-25 | S, sale reported on Form 4 | 130,000 | $3.9M | 2021-10-26 |
| 2022-03-02 | S, sale reported on Form 4 | 4,849 | $58.2K | 2022-03-04 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1837648) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms